Home / Merck & Co., Inc. (MRK)

Merck & Co., Inc. (MRK) Technical Analysis

Updated: 2026-06-16 09:32 UTC · Last close: 114.90 (-3.49%) · Support: 108.11 · Resistance: 116.06
Merck & Co., Inc. (MRK) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
⬇️ Support
108.11
⬆️ Resistance
116.06
⚠️ Risk Line
losing 108.13 would weaken the current structure.
🔺 Technical Setup
Pattern
Triangle Compression / SYM / DOWN
State
Forming
Breakout Watch
Downtrend line not broken yet · score 0
Watch Level
122.75
Compression
47%
RSI(14)
45.0
🎯 Decision Map
The nearest decision zone is framed by support around 108.13 and resistance near 116.42. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.
📊 Technical Summary
At a glance
Trend
Mixed
Momentum
Neutral
Range
81% of 52W range
Key Zone
108.11 / 116.06
The latest close for Merck & Co., Inc. (MRK) came in at 114.90 (-3.49%). Medium-term tone has softened, but price remains above MA200. Momentum stays positive (+3.16%), with 52W position: 80% of range, while Volatility: ATR14 2.84%. RSI(14) is 45.0, leaving momentum in a fairly neutral range. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD remains below its signal line, which shows that momentum confirmation is still limited. The MACD histogram is negative and weakening further, which reflects continued downside pressure.
🔺
Setup: Pattern Triangle compression remains the main pattern under review.
🎯
Key levels: Near-term structure is defined by support at 108.11 and resistance at 116.06.
🚀
Trigger: A clean break above resistance would strengthen the chart, while a loss of support would put the current setup under pressure.
💼 Fundamentals Snapshot
Source: sec
💼 Business Lens
QUALITY VIEW
Financial quality snapshot
Financial pressure is elevated
📈 Growth: Improving 💰 Profit: Negative 💵 Cash: Pressured 🛡 Balance: Manageable
• Quarterly revenue is improving again after a softer stretch.
• Quarterly profitability remains weak, with net margin below zero.
💵 Revenue
16.29B
📈 Net Income
-4.24B
🧮 EPS (Basic)
-1.72
🏢 Company
Merck & Co., Inc.
🏷 Sector
Healthcare
🧩 Industry
Pharma
Compare with related stocks
Same sector and industry ideas for deeper research
AbbVie (ABBV) technical analysisAstrazeneca (AZN) technical analysisBristol-Myers Squibb Company (BMY) technical analysisJohnson & Johnson (JNJ) technical analysisELI LILLY & Co (LLY) technical analysisPfizer (PFE) technical analysisTeva Pharmaceutical Industries (TEVA) technical analysis
WOI OPEN ADVANCED ANALYSIS WORKSPACE
Note: This is an algorithmic technical snapshot (not financial advice).
MRK Chart